News Conference News ESC 2025 ALONE-AF: Less Bleeding When OAC Stopped After Successful Ablation Todd Neale September 08, 2025
Presentation ESC 2025 ABC-AF study: Pragmatic registry-based randomised controlled trial of personalised treatment to reduce stroke or death in atrial fibrillation Presenter: Jonas Oldgren August 30, 2025
News Conference News ESC 2024 Asundexian for AF? More Details on the Sinking of OCEANIC-AF Shelley Wood September 02, 2024
Presentation ESC 2024 OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation Presenter: Manesh R. Patel September 01, 2024
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
Presentation ESC 2021 Implantable Loop Recorder to Detect Atrial Fibrillation and Prevent Stroke (The LOOP Study): A Randomised Controlled Trial Presenter: Jesper Hastrup Svendsen August 31, 2021
News Conference News ESC 2019 Increasing Oral Anticoagulation Use Tied to Less Ischemic Stroke in A-fib Patients in Italy Todd Neale August 31, 2019
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Conference News ESC 2015 Danish Registry Study Shows Potential of Stroke Risk Score in Heart Failure Patients L.A. McKeown August 31, 2015
News Conference News ESC 2013 New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups Caitlin E. Cox September 03, 2013